Compare PSEC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSEC | INSP |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2018 |
| Metric | PSEC | INSP |
|---|---|---|
| Price | $2.28 | $41.89 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $2.50 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 6.4M | 1.1M |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 20.07% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $2.11 | $38.91 |
| 52 Week High | $3.50 | $147.03 |
| Indicator | PSEC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 40.09 | 40.08 |
| Support Level | $2.11 | $39.61 |
| Resistance Level | $2.95 | $44.98 |
| Average True Range (ATR) | 0.08 | 2.33 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 43.21 | 49.92 |
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.